37 related articles for article (PubMed ID: 14236928)
21. A MOLECULAR BASIS FOR DRUG ACTION. THE INTERACTION OF ONE OR MORE DRUGS WITH DIFFERENT RECEPTORS.
ARIUENS EJ; SIMONIS AM
J Pharm Pharmacol; 1964 May; 16():289-312. PubMed ID: 14198426
[No Abstract] [Full Text] [Related]
22. [PHARMACOLOGY IN PREGNANCY. II].
MACCARINI PA; AGUZZOLI RS
Clin Ter; 1964 Jul; 30():151-86. PubMed ID: 14187091
[No Abstract] [Full Text] [Related]
23. PROTOZOA AS TOXICOLOGIC TOOLS.
HUTNER SH
J Protozool; 1964 Feb; 11():1-6. PubMed ID: 14119556
[No Abstract] [Full Text] [Related]
24. [COMPLICATIONS IN INTRAVENOUS UROGRAPHY].
SKOKAN ZV
Lek Veda Zahr; 1964 Aug; 8():155-60. PubMed ID: 14198819
[No Abstract] [Full Text] [Related]
25. AMPHETAMINE TOXICITY, POPULATION DENSITY, AND BEHAVIOR: A REVIEW.
THIESSEN DD
Psychol Bull; 1964 Dec; 62():401-10. PubMed ID: 14242593
[No Abstract] [Full Text] [Related]
26. How reserpine and chlorpromazine act: the impact of key discoveries on the history of psychopharmacology.
Curzon G
Trends Pharmacol Sci; 1990 Feb; 11(2):61-3. PubMed ID: 2180160
[No Abstract] [Full Text] [Related]
27. CHEMICALLY (TCP) INDUCED FIBRE DEGENERATION IN THE CENTRAL NERVOUS SYSTEM, WITH REFERENCE TO CLINICAL AND NEUROPHARMACOLOGICAL ASPECTS.
GLEES P; JANZIK H
Prog Brain Res; 1965; 14():97-121. PubMed ID: 14317763
[No Abstract] [Full Text] [Related]
28. Effects of chlorpromazine on learning.
Hartlage LC
Psychol Bull; 1965 Oct; 64(4):235-45. PubMed ID: 5318039
[No Abstract] [Full Text] [Related]
29. AN APPRAISAL OF ANIMAL DRUG SCREENING TECHNIQUES USED IN PSYCHOPHARMACOLOGY.
CARR CJ
J New Drugs; 1963; 3(3):135-46. PubMed ID: 14051956
[No Abstract] [Full Text] [Related]
30. BEHAVIORAL PHARMACOLOGY.
GOLLUB LR; BRADY JV
Annu Rev Pharmacol; 1965; 5():235-62. PubMed ID: 14287882
[No Abstract] [Full Text] [Related]
31. HISTAMINE.
KAHLSON G; ROSENGREN E
Annu Rev Pharmacol; 1965; 5():305-20. PubMed ID: 14287886
[No Abstract] [Full Text] [Related]
32. HISTAMINE AND THE REVERSAL OF CHLORPROMAZINE-INDUCED DEPRESSION.
ROSENBERG FJ; SAVARIE PJ
J Pharmacol Exp Ther; 1964 Nov; 146():180-5. PubMed ID: 14236928
[No Abstract] [Full Text] [Related]
33. REVIEW OF ANTIMOTION SICKNESS DRUGS FROM 1954-1964.
WOOD CD; KENNEDY RS; GRAYBIEL A
Aerosp Med; 1965 Jan; 36():1-4. PubMed ID: 14243672
[No Abstract] [Full Text] [Related]
34. NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
Faurbye A; Rasch PJ; Petersen PB; Brandborg G; Pakkenberg H
Acta Psychiatr Scand; 1964; 40(1):10-27. PubMed ID: 14217630
[No Abstract] [Full Text] [Related]
35. [COMPOUNDS WITH VITAMIN P-LIKE ACTION AND FLAVONOIDS].
RAVINA A
Presse Med (1893); 1964 Nov; 72():2855-7. PubMed ID: 14223268
[No Abstract] [Full Text] [Related]
36. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION].
HOLMBERG G; SJOEQVIST F
Sven Lakartidn; 1964 Dec; 61():3762-93. PubMed ID: 14276462
[No Abstract] [Full Text] [Related]
37. EFFECTS OF DRUGS ON METABOLISM OF THE BRAIN IN VITRO.
QUASTEL JH
Br Med Bull; 1965 Jan; 21():49-56. PubMed ID: 14292500
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
